688298 Stock Overview
Zhejiang Orient Gene Biotech Co., Ltd. researches and develops, produces, and sells in vitro diagnostic products worldwide.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 4/6 |
Dividends | 0/6 |
Zhejiang Orient Gene Biotech Co.,Ltd Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CN¥28.34 |
52 Week High | CN¥45.44 |
52 Week Low | CN¥25.00 |
Beta | 1.74 |
11 Month Change | -0.14% |
3 Month Change | -7.20% |
1 Year Change | -25.52% |
33 Year Change | -79.81% |
5 Year Change | n/a |
Change since IPO | -74.72% |
Recent News & Updates
Recent updates
Shareholder Returns
688298 | CN Biotechs | CN Market | |
---|---|---|---|
7D | 1.2% | -2.0% | -1.9% |
1Y | -25.5% | -19.7% | -15.8% |
Return vs Industry: 688298 underperformed the CN Biotechs industry which returned -19.7% over the past year.
Return vs Market: 688298 underperformed the CN Market which returned -15.8% over the past year.
Price Volatility
688298 volatility | |
---|---|
688298 Average Weekly Movement | 5.4% |
Biotechs Industry Average Movement | 6.2% |
Market Average Movement | 6.7% |
10% most volatile stocks in CN Market | 10.2% |
10% least volatile stocks in CN Market | 4.1% |
Stable Share Price: 688298 has not had significant price volatility in the past 3 months.
Volatility Over Time: 688298's weekly volatility (5%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2005 | 2,231 | Xiaoliang Fang | www.orientgene.com |
Zhejiang Orient Gene Biotech Co., Ltd. researches and develops, produces, and sells in vitro diagnostic products worldwide. The company offers IFA solutions, digital test, oral fluid test, and covid-19 test products; and immunological diagnosis product, such as hair drug test kit, monkeypox, saliva drug test, urine multi-drug test, urine single-drug test, rapid test, digital pregnancy test, male-fertility test, menopause test, and other test products.
Zhejiang Orient Gene Biotech Co.,Ltd Fundamentals Summary
688298 fundamental statistics | |
---|---|
Market cap | CN¥5.71b |
Earnings (TTM) | -CN¥414.61m |
Revenue (TTM) | CN¥627.03m |
9.1x
P/S Ratio-13.8x
P/E RatioIs 688298 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
688298 income statement (TTM) | |
---|---|
Revenue | CN¥627.03m |
Cost of Revenue | CN¥511.30m |
Gross Profit | CN¥115.73m |
Other Expenses | CN¥530.34m |
Earnings | -CN¥414.61m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -2.06 |
Gross Margin | 18.46% |
Net Profit Margin | -66.12% |
Debt/Equity Ratio | 2.3% |
How did 688298 perform over the long term?
See historical performance and comparison